Clinical Trials on Positron Emission Tomography in Belgium

Total 21 results

Universitaire Ziekenhuizen KU Leuven

Recruiting

The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus

Status Epilepticus | Positron-emission Tomography | Ictal-interictal Continuum | Perfusion Weighted MRI | Perfusion CT

Belgium
University Ghent
Federal Agency for Nuclear Control, Belgium

Completed

Low Dose Effects of X-rays in Pediatric Patients Undergoing a CT Examination. (PedCTBe)

Pediatric Patients Undergoing a Computed Tomography Examination

Belgium
University Ghent

Completed

Evaluation of the Impact of the PRONEtect Education Hub vs. Classic Lecture, on the Competencies of Nursing Students

Pressure Ulcer | Prone Position

Belgium
Joost Daemen
Horizon 2020 - European Commission; REVA Medical, Inc.

Recruiting

FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I Study

Percutaneous Coronary Intervention | Tomography, Optical Coherence | Myocardial Revascularization

Netherlands, Belgium
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Completed

The Use of 2D and 3D Imaging Modalities and Its Influence on Diagnosis and Treatment Planning in Orthodontics

Malocclusion | Orthodontics | Cone-Beam Computed Tomography | Panoramic Radiography | Impacted Tooth | Cephalometry

Belgium
University Ghent

Completed

Online Cognitive Control Training for Remitted Depressed Patients

Major Depression in Remission

Belgium
University Ghent

Withdrawn

Online Contingent Attention Training (OCAT)

Major Depression in Remission

Belgium
University Ghent

Completed

Cognitive Control Training for Remitted Depressed Patients

Major Depression in Remission

Belgium
University Ghent
University Hospital, Ghent; Research Foundation Flanders

Recruiting

Effects of Booster Sessions on Depression Vulnerability Following Cognitive Control Training

Major Depression in Remission

Belgium
University Ghent
University Hospital, Ghent; Research Foundation Flanders

Completed

Optimal Dose of a Cognitive Control Training for Depression Vulnerability

Major Depression in Remission

Belgium
University Hospital, Antwerp

Terminated

Car Safety Seat and Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease and Position

Belgium
KU Leuven

Recruiting

Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)

Healthy Controls | IBS | Ulcerative Colitis, Active | Ulcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms) | Crohn's Disease, Active | Crohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)

Belgium
Hyperfusion
University Hospital, Ghent

Unknown

DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria

Metastatic Lung Cancer | Cancer, Lung | Metastatic Liver Cancer | Cancer Liver | Perfusion Computed Tomography Target Lesion

Belgium
University Hospital, Ghent

Completed

5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scores (TRP-IBD)

Fatigue | Crohn Disease | Ulcerative Colitis | Remission

Belgium
Jules Bordet Institute

Unknown

Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia (ASCI)

Effects of Immunotherapy | Acute Myelogenous Leukemia | Myeloid Leukemia in Remission

Belgium
Universiteit Antwerpen
Belgian Federal Public Service, Food Chain Safety and Environment

Completed

Prevention of Serious Adverse Events in Acute Care Hospitals by Afferent Limb and Response Method Intervention - the ALARM Intervention Study. (ALARM)

Death, Sudden, Cardiac | Unexpected Hospital Mortality | Unplanned Intensive Care Unit Admission

Belgium
University of Liege
Belgian Hematological Society

Recruiting

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning (HLA)

Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Non Hodgkin Lymphoma | Myeloproliferative Disorder | Chronic Lymphoid Leukemia | Acute Myeloid Leukemia in Remission | Myeloproliferative Syndrome | Chronic Myeloid Leukemia in Remission | Acute Lymphoid Leukemia in Remission

Belgium
Assistance Publique - Hôpitaux de Paris
Imagine Institute; Axonal-Biostatem; CERBA laboratory; SATT; SNC Graft Versus Host...

Recruiting

Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft (Predictor2)

Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia in Remission | Lymphoma in Remission | Non-progressive Myeloproliferative Syndrome | Myelodysplasia With Stable Blasts is Cell Number and < 10% of Blastocysts | Acute Leukemia Biphenotypic in Remission

France, Germany, Belgium
University Hospital Inselspital, Berne

Completed

Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis (INVEST)

Drug-Eluting Stents | Coronary Thrombosis | Tomography, Optical Coherence

Austria, Belgium, France, Germany, Hong Kong, Italy, Netherlands, Singapore, Spain, Switzerland
Vastra Gotaland Region

Recruiting

Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML (SCRIPT-AML)

Stem Cell Transplantation | Acute Myeloid Leukemia (AML) in Remission

Belgium, Denmark, Finland, Hong Kong, Israel, Lithuania, Netherlands, Norway, Spain, Sweden
Stichting Hemato-Oncologie voor Volwassenen Nederland
Nordic CLL Study Group

Active, not recruiting

A Prospective, Multicenter, Phase-II Trial of Ibrutinib Plus Venetoclax in Patients With Creatinine Clearance >= 30 ml/Min Who Have Relapsed or Refractory Chronic Lymphocytic Leukemia (RR-CLL) With or Without TP53 Aberrations

Chronic Lymphocytic Leukemia in Relapse | Chronic Lymphocytic Leukemia in Remission

Netherlands, Belgium, Denmark, Finland, Norway, Sweden

Clinical Trials on Positron Emission Tomography in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations